LAMEA Spine Bone Stimulators Market

LAMEA Spine Bone Stimulators Market Size, Share & Industry Trends Analysis Report By Device Type (Non-Invasive and Invasive), By End User (Hospitals, Specialty Clinics, and Others), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-9425 Publication Date: May-2022 Number of Pages: 62
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Spine Bone Stimulators Market would witness market growth of 6.0% CAGR during the forecast period (2022-2028).

After surgery, the patient can use an electric bone growth stimulation to enhance the capability of the bones to develop and fuse. There are two sorts of devices those are implanted via surgery and those that are worn on the outside like a brace. Researchers discovered that all these electrical stimulation gadgets were able to increase fusion rates in patients, making fusion twice as likely. The inclusion of a spine stimulator, with the goal of successful bone fusion, is a considerable benefit and can enhance outcomes.

All patients receiving lumbar or cervical spine fusions are advised to employ an electrical bone growth stimulator to increase the overall probability of achieving bone fusion. The more effective the fusion, the more likely the patient would have a good prognosis and be able to resume their favorite activities.

Non-union can be treated in a variety of ways, including operation, internal or external bracing, bone grafting, or the use of synthetic bone substitutes. A durable medical equipment device called a Bone Growth Stimulator is the least intrusive and only non-surgical approach. When bones repair or develop, they produce a moderate electric field.

The key forces fueling the market's growth in South Africa are the rising number of spinal injuries and the presence of organizations such as SASCA and the South African Spine Society. The South African Spine Society is a non-profit organization dedicated to fostering continuing medical education for healthcare professionals and sharing information regarding spine disorders. These groups' participation is expected to increase public awareness. Many technological advances in spinal surgery have been accomplished in the last decade.

Spinal navigational technology is one of the most recent developments, allowing surgeons to implant spine gear accurately and perform decompression with precision. A smaller incision, less damage to normal tissues, faster healing time, and faster recovery are all possible with such improvements. Several additional reasons, such as the increasing use of minimally invasive procedures, are expected to drive the market ahead over the projection period. In South Africa, technological advancements and the introduction of novel technologies are driving the market for spine bone stimulator equipment.

The Brazil market dominated the LAMEA Spine Bone Stimulators Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $9.6 million by 2028. The Argentina market is poised to grow at a CAGR of 6.6% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 5.8% during (2022 - 2028).

Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Spine Bone Stimulators Market is Predict to reach $626.2 Million by 2028, at a CAGR of 4.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc

Recent Strategies Deployed in Spine Bone Stimulators Market

  • May-2022: Orthofix Medical received a U.S. Food and Drug Administration for AccelStim bone healing treatment Class III device. The AccelStim device offers an effective and safe nonsurgical therapy for demonstrating fresh fractures and for fractures that have not to cure.
  • Mar-2022: Zimmer Biomet signed an agreement with Biocomposites, an international medical device enterprise. Together the companies aimed to solely administer its Genex bone graft replacement with its new combining system and provide options in the US orthopedic industry. Additionally, genex bone graft substitute tools to surgeons to proceed in business to mitigate enhancement and pain the capacity of life for consumers across the world.
  • Feb-2022: DJO extended its partnership with the Professional Football Athletic Trainers Society, an experienced society composed of authorized athletic coaches working in professional football. Through this partnership, the entities aimed to promote athlete health through schemes such as join the Club, DJO’s precautionary uplifting scheme for high school sportspersons.
  • Sep-2021: DJO, a subsidiary of Colfax Corporation unveiled MedShape DynaNail Hybrid Fusion System. The DynaNail Hybrid adaptive, active healing to deliver cutting-edge, creative automation to patients that would get them back on their feet earlier and keep them effective for longer.
  • Apr-2021: Orthofix Medical signed an agreement to commercialize the innovative suite of IGEA, cartilage, and soft tissue stimulation products in the U.S and Canada. Through this agreement, Orthofix has the right to attempt U.S Food and Drug Administration commercialization and acceptance of IGEA’s policy on orthopedic products, which are not presently accessible in the U.S.
  • Nov-2018: DJO came into a partnership with SirenMD, a technology platform that powers athlete health by connecting the trainers, physicians, and loved ones who treat them. Through this partnership, the companies aimed to address some of the medical carelessness with an integrated telecommunications platform and enhance complete patient healthcare.

Scope of the Study

Market Segments Covered in the Report:

By Device Type

  • Non-Invasive
  • Invasive

By End User

  • Hospitals
  • Specialty Clinics
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • DJO Global, Inc. (Enovis)
  • Zimmer Biomet
  • Orthofix Medical Inc.
  • Elizur Corporation
  • Ossatec Benelux BV
  • IGEA S.p.A.
  • ManaMed Inc.
  • Theragen, Inc.
  • Intelligent Implants
  • Orchid Medical, Inc.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo